Two fibromyalgia drugs refused EU endorsements
This article was originally published in Scrip
Executive Summary
The CHMP has refused to recommend two potential therapies for fibromyalgia – Pfizer's Lyrica (pregabalin) and Pierre Fabre's milnacipran – for approval in the EU.